|
| 37971860 | Identifying and distinguishing cognitive profiles among virally suppressed people with HIV. | Neuropsychology | 2024 |
| 37553288 | Cannabis use may attenuate neurocognitive performance deficits resulting from methamphetamine use disorder. | J Int Neuropsychol Soc | 2024 |
| 38059529 | Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIV. | J Infect Dis | 2024 |
| 38051787 | The clinical utility of three frailty measures in identifying HIV-associated neurocognitive disorders. | AIDS | 2024 |
| 37989461 | Mitochondrial DNA mutation pathogenicity score and neurocognitive performance in persons with HIV. | Mitochondrion | 2024 |
| 37939156 | Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIV. | AIDS | 2024 |
| 36318881 | Brief Report: Sex Differences in the Association Between Cerebrovascular Function and Cognitive Health in People Living With HIV in Urban China. | J Acquir Immune Defic Syndr | 2023 |
| 37632053 | Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs. | Viruses | 2023 |
| 37704201 | CROI 2023: Neuropsychiatric Complications in People With HIV. | Top Antivir Med | 2023 |
| 37651083 | Combined effects of loneliness and inflammation on depression in people with HIV. | J Neurovirol | 2023 |
| 37943478 | The relationship between synaptodendritic neuropathology and HIV-associated neurocognitive disorders is moderated by cognitive reserve. | J Neurovirol | 2023 |
| 37766283 | Reply to Augello, P.A.; Wu, J. Comment on "Rogers et al. The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition. <i>Viruses</i> 2023, <i>15</i>, 674". | Viruses | 2023 |
| 37766242 | Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIV. | Viruses | 2023 |
| 37289360 | Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression. | J Neurovirol | 2023 |
| 37155086 | A longitudinal study of cannabis use and risk for cognitive and functional decline among older adults with HIV. | AIDS Behav | 2023 |
| 36992383 | The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition. | Viruses | 2023 |
| 37183889 | Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus. | Clin Infect Dis | 2023 |
| 37082207 | Subacute myoclonic measles encephalitis - An opportunistic HIV-associated infection. | Front Cell Neurosci | 2023 |
| 37347049 | Sex-specific associations between plasma interleukin-6 and depression in persons with and without HIV. | Brain Behav Immun Health | 2023 |
| 37110445 | Signatures of HIV and Major Depressive Disorder in the Plasma Microbiome. | Microorganisms | 2023 |
| 37206541 | PKR-like ER kinase (PERK) Haplotypes Are Associated with Depressive Symptoms in People with HIV. | J Neurol Psychol | 2023 |
| 37139648 | Stimulating dissemination of research that addresses the social and contextual drivers of HIV prevention and treatment in the journal AIDS. | AIDS | 2023 |
| 36477867 | Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study. | Brain | 2023 |
| 36580636 | Anemia and Erythrocyte Indices Are Associated With Neurocognitive Performance Across Multiple Ability Domains in Adults With HIV. | J Acquir Immune Defic Syndr | 2023 |
| 36769155 | Time of Day Influences Concentrations of Total Protein and Albumin in Cerebrospinal Fluid in HIV. | Int J Mol Sci | 2023 |
| 36930640 | Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology. | J Infect Dis | 2023 |
| 36930639 | Cognitive Health in Persons With Human Immunodeficiency Virus: The Impact of Early Treatment, Comorbidities, and Aging. | J Infect Dis | 2023 |
| 36729300 | Effect of coinfections on neurocognitive functioning among people with clade C HIV infection in Zambia. | J Neurovirol | 2023 |
| 36792952 | Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes. | AIDS Res Hum Retroviruses | 2023 |
| 36310512 | Higher Levels of Cerebrospinal Fluid and Plasma Neurofilament Light in Human Immunodeficiency Virus-Associated Distal Sensory Polyneuropathy. | Clin Infect Dis | 2023 |
| 36322713 | Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging Workshop. | AIDS Res Hum Retroviruses | 2023 |
| 34287757 | A Cross-Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men. | AIDS Behav | 2022 |
| 35773234 | Neuropathic pain correlates with worsening cognition in people with human immunodeficiency virus. | Brain | 2022 |
| 35674935 | Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment. | J Neurovirol | 2022 |
| 35364601 | Cognitive and Physiologic Reserve Independently Relate to Superior Neurocognitive Abilities in Adults Aging With HIV. | J Acquir Immune Defic Syndr | 2022 |
| 35389174 | The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV. | J Neurovirol | 2022 |
| 37205974 | Astrocyte Activation is A Potential Mechanism Underlying Depressed Mood and Apathy in People with HIV. | J Neurol Psychol | 2022 |
| 36439059 | Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV. | Brain Behav Immun Health | 2022 |
| 36260191 | Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program. | Curr HIV/AIDS Rep | 2022 |
| 36347056 | CROI 2022: neurologic complications of HIV-1, SARS-CoV-2, and other pathogens. | Top Antivir Med | 2022 |
| 35157246 | Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid. | J Neurovirol | 2022 |
| 34855982 | Polypharmacy in older adults with HIV infection: Effects on the brain. | J Am Geriatr Soc | 2022 |
| 35313166 | Soluble CD14 is subtype-dependent in serum but not in cerebrospinal fluid in people with HIV. | J Neuroimmunol | 2022 |
| 35090158 | Higher Cerebrospinal Fluid Soluble Urokinase-type Plasminogen Activator Receptor, But Not Interferon γ-inducible Protein 10, Correlate With Higher Working Memory Deficits. | J Acquir Immune Defic Syndr | 2022 |
| 35202052 | Neopterin Relates to Lifetime Depression in Older Adults With HIV on Suppressive Antiretroviral Therapy. | J Acquir Immune Defic Syndr | 2022 |
| 34427814 | Correction to: A Crossâ¿¿Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men. | AIDS Behav | 2022 |
| 32157292 | Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy. | J Infect Dis | 2021 |
| 33571816 | Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy. | J Neuroimmunol | 2021 |
| 33651324 | Gut microbiota dysbiosis is associated with worse emotional states in HIV infection. | J Neurovirol | 2021 |
| 33621803 | Telomere length is associated with HIV infection, methamphetamine use, inflammation, and comorbid disease risk. | Drug Alcohol Depend | 2021 |